Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Kepe

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Journal of Nutrition, Health & Aging|January 1, 2008
Amyloid and tau imaging, neuronal losses and function in mild cognitive impairmentJ R Barrio, V Kepe, N Satyamurthy, et al.
Neuroscience|March 6, 2003
In vitro detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer's brain using the positron emission tomography molecular imaging probe 2-(1-[6-[(2-[(18)F]fluoroethyl)(methyl)amino]-2-naphthyl]ethylidene)malononitrileE D Agdeppa, V Kepe, A Petri, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 6, 2001
Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's diseaseE D Agdeppa, V Kepe, J Liu, et al.
Neuroimage|August 26, 2009
FDDNP binding using MR derived cortical surface mapsH D Protas, S-C Huang, V Kepe, et al.
International Journal of Geriatric Psychiatry|March 3, 2012
Assessment of dementia risk in aging adults using both FDG-PET and FDDNP-PET imagingL M Ercoli, G W Small, P Siddarth, et al.
Neurology|July 20, 2007
Amyloid imaging in distinguishing atypical prion disease from Alzheimer diseaseA L Boxer, G D Rabinovici, V Kepe, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Journal of Nutrition, Health & Aging|January 1, 2008
Amyloid and tau imaging, neuronal losses and function in mild cognitive impairmentJ R Barrio, V Kepe, N Satyamurthy, et al.
Neuroscience|March 6, 2003
In vitro detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer's brain using the positron emission tomography molecular imaging probe 2-(1-[6-[(2-[(18)F]fluoroethyl)(methyl)amino]-2-naphthyl]ethylidene)malononitrileE D Agdeppa, V Kepe, A Petri, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 6, 2001
Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's diseaseE D Agdeppa, V Kepe, J Liu, et al.
Neuroimage|August 26, 2009
FDDNP binding using MR derived cortical surface mapsH D Protas, S-C Huang, V Kepe, et al.
International Journal of Geriatric Psychiatry|March 3, 2012
Assessment of dementia risk in aging adults using both FDG-PET and FDDNP-PET imagingL M Ercoli, G W Small, P Siddarth, et al.
Neurology|July 20, 2007
Amyloid imaging in distinguishing atypical prion disease from Alzheimer diseaseA L Boxer, G D Rabinovici, V Kepe, et al.
Pageof 1